# Contact TB-500 Clinic: Editorial Correspondence Only

> Contact TB-500 Clinic, the independent editorial dossier on TB-500 and thymosin beta-4. Editorial correspondence and corrections only — no clinical, prescribing, or sales inquiries.

Editorial correspondence and corrections to the dossier. We do not provide medical advice, prescriptions, or products.

## What to write about

Contact TB-500 Clinic for editorial matters: a correction to a cited study, a question about how a finding is characterized, a source we should consider, or feedback on the dossier. We read every message that concerns the accuracy of the TB-500 and thymosin beta-4 literature as we summarize it.

We cannot help with anything clinical or commercial. We do not give medical advice, do not recommend doses, do not write or fill prescriptions, and do not sell, supply, or source any substance. Messages asking where to obtain TB-500, or asking for a dosing protocol, will not receive that information — the site exists to read the published record, not to facilitate use.

## Corrections policy

Accuracy is the whole value of an editorial dossier, so corrections are welcome and acted on. If a citation is mismatched to a claim, a figure is wrong, or a study is misattributed between full-length thymosin beta-4 and the TB-500 fragment, tell us which page and which reference and we will verify it against the source and fix it. The fragment-versus-protein distinction is the one we most want kept exact, because it is the one most easily blurred.

## Send a message

Use the form below for editorial correspondence. Please include the page and the reference number where relevant; it makes a correction far faster to verify. This form is for editorial contact only and is not a clinical, prescribing, or sales channel.

We do not collect information for marketing, and we have no products to market. A message here reaches the people who maintain the dossier, and the most useful ones point at a specific claim on a specific page. If your note is about whether a finding belongs to full-length thymosin beta-4 or to the TB-500 fragment, say so plainly — that is the distinction this site is built to protect, and the one we most want to get right.

---

A cinematic dark-folio reading of the thymosin beta-4 literature, kept honest about where the Ac-LKKTETQ fragment's human data stop — an editorial dossier, never a clinic and nothing dispensed.